Does TRIHEPTANOIN Cause Off label use? 48 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 48 reports of Off label use have been filed in association with TRIHEPTANOIN (DOJOLVI). This represents 9.6% of all adverse event reports for TRIHEPTANOIN.
48
Reports of Off label use with TRIHEPTANOIN
9.6%
of all TRIHEPTANOIN reports
8
Deaths
10
Hospitalizations
How Dangerous Is Off label use From TRIHEPTANOIN?
Of the 48 reports, 8 (16.7%) resulted in death, 10 (20.8%) required hospitalization, and 1 (2.1%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRIHEPTANOIN. However, 48 reports have been filed with the FAERS database.
What Other Side Effects Does TRIHEPTANOIN Cause?
Vomiting (79)
Diarrhoea (70)
Rhabdomyolysis (53)
Abdominal pain upper (38)
Abdominal discomfort (34)
Blood creatine phosphokinase increased (34)
Death (29)
Nausea (26)
Gastrointestinal disorder (23)
Hospitalisation (22)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which TRIHEPTANOIN Alternatives Have Lower Off label use Risk?
TRIHEPTANOIN vs TRIHEXYPHENIDYL
TRIHEPTANOIN vs TRILACICLIB
TRIHEPTANOIN vs TRILEPTAL
TRIHEPTANOIN vs TRIMEBUTINE
TRIHEPTANOIN vs TRIMEPRAZINE